Partnering &

Cura Therapeutics is actively seeking strategic partnering opportunities, and collaborations with pharmaceutical and biotechnology companies to develop and commercialize cancer immunotherapies based on our multifunctional fusion proteins.

Cura Therapeutics is building an innovative immunotherapy platform of first-in-class treatments that target multiple mechanisms of the most aggressive forms of cancers.

To learn more about Cura Therapeutics and opportunities for partnering & collaborations, complete the form below.

Name *